MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$305,106K Accounts receivable, net$251,062K Inventories, net$31,515K Prepaid and othercurrent assets$23,523K Total current assets$611,206K Intangible asset, net$38,947K Non-current inventory andother assets$30,831K Right-of-use asset -operating lease$20,014K Goodwill$12,042K Equipment, net$567K Total assets$713,607K Total liabilities andstockholders equity$713,607K Total liabilities$659,020K Total stockholdersequity$54,587K Accumulated deficit-$1,370,503K Total currentliabilities$439,211K Loan payable,long-term$117,850K Contingent consideration,non-current$73,730K Operating leaseliability, long-term$22,385K Finance leaseliability, long-term$5,844K Additional paid-in capital$1,425,085K Common stock, 0.0001par value per share...$5K Accrued expenses andother current...$250,731K Accounts payable$106,702K Short-term borrowings$70,000K Contingent consideration,current$11,150K Operating leaseliability, current portion$628K
Balance Sheet

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)

source: myfinsight.com